An Act relative to prescription drug pricing
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill, An Act relative to prescription drug pricing, aims to address the high cost of prescription medications in Massachusetts. It seeks to increase transparency in drug pricing and potentially limit the ability of pharmaceutical companies to set prices without justification. The bill’s specific mechanisms are still being developed through committee review and potential amendments. It builds upon previous efforts to tackle prescription drug costs in the state.
Key provisions
- Requires the Department of Public Health to report on prescription drug prices.
- Establishes a process for reviewing and potentially challenging excessive drug prices.
- May explore strategies to negotiate drug prices.
- Focuses on increasing transparency in the drug pricing process.
- Could potentially limit the practice of ‘spread pricing’ by pharmaceutical companies.
Who is affected
- Patients in Massachusetts
- Prescription drug manufacturers
- Pharmaceutical distributors
- Healthcare providers
- The state’s healthcare system
Notable changes
- The bill seeks to build upon previous legislation addressing drug pricing transparency.
- It aims to provide greater oversight of drug pricing practices.
- Specific pricing negotiation mechanisms are still under consideration.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours